Our Daily Meds

Our Daily Meds examines the pharmaceutical industry's marketing practices and their impact on American healthcare. Through research and interviews, journalist Melody Petersen documents how drug companies promote their products to doctors and consumers. The book traces the evolution of prescription drug marketing from the mid-20th century to present day, analyzing changes in advertising regulations and medical culture. Petersen draws on her experience as a New York Times reporter covering the pharmaceutical beat to investigate industry sales tactics and their consequences. The narrative incorporates stories of patients, physicians, and pharmaceutical representatives while exploring the economics behind drug development and promotion. Statistical data and historical examples illustrate the growth of prescription medication use in America. This investigative work raises questions about the relationship between profit motives and public health, while examining how marketing shapes both medical practice and patient expectations. The book contributes to ongoing debates about healthcare costs, medical ethics, and corporate influence in medicine.

Readers describe Our Daily Meds as an exposé of pharmaceutical industry marketing practices and their impact on American healthcare costs. The book draws heavily from Petersen's decade of reporting on the pharmaceutical industry for the New York Times. Readers appreciated: - Detailed documentation and extensive research - Clear explanations of complex industry practices - Personal patient stories that illustrate broader issues - Coverage of drug pricing and marketing tactics Common criticisms: - Some sections feel repetitive - Focus primarily on negative aspects without balanced coverage - Limited discussion of potential solutions - Writing style can be dry in technical sections Ratings: Goodreads: 3.9/5 (265 ratings) Amazon: 4.3/5 (89 ratings) Multiple readers noted the book changed their perspective on prescription medications, with one Amazon reviewer stating: "This book should be required reading for anyone taking prescription drugs." Several medical professionals praised its accuracy but suggested it oversimplifies some regulatory issues.

Bad Pharma by Ben Goldacre Documents how pharmaceutical companies manipulate clinical trials and withhold data that affects patient care.

The Truth About the Drug Companies by Marcia Angell Chronicles the business practices of pharmaceutical companies and their influence on medical research, drug prices, and healthcare policy.

White Coat, Black Hat by Carl Elliott Examines the commercialization of medicine through stories of drug reps, researchers, and physicians involved in pharmaceutical marketing.

Overdosed America by John Abramson Reveals how the commercialization of medical knowledge distorts healthcare decisions and impacts patient outcomes.

The Big Fix by Katharine Eban Investigates pharmaceutical fraud, manufacturing issues, and quality control problems in the global medicine supply chain.

🔹 Author Melody Petersen spent four years as a staff reporter covering the pharmaceutical industry for The New York Times before writing this investigative exposé. 🔹 The book reveals that in 2004, pharmaceutical companies spent $4 billion on consumer advertising in the United States - nearly double what they spent in 2000. 🔹 Petersen documents how the number of FDA-approved drug salespeople grew from 38,000 in 1995 to about 100,000 by 2005, a number that exceeded the total number of students graduating from medical schools during those years. 🔹 The pharmaceutical industry spends approximately $30,000 per year marketing directly to each physician in the United States, according to research cited in the book. 🔹 The book details how pharmaceutical companies began marketing conditions like "social anxiety disorder" to expand their market, transforming what was once considered normal shyness into a treatable medical condition.